Effectiveness of phosphatidylcholine in alleviating steatosis in patients with non-alcoholic fatty liver disease and cardiometabolic comorbidities (MANPOWER study).

Igor V MaevAleksey A SamsonovLiudmila K PalgovaChavdar S PavlovElena I VovkElena N ShirokovaKirill M Starostin

Published in: BMJ open gastroenterology (2020)

This study showed that PPC adjunctive therapy may be useful in improving the ultrasonographic features of NAFLD in patients with associated cardiometabolic comorbidities. It also supports evidence regarding the role of PPC in the complex management of NAFLD.

Keyphrases

systematic review
type diabetes
stem cells
metabolic syndrome
high fat diet
bone marrow
skeletal muscle
cell therapy
smoking cessation